Sep 29, 2014 05:19 AM EDT
Perjeta Breast Cancer Drug Shows 'Unprecedented' Benefits For Extended Survival
A new breast cancer treatment by the Swiss drug maker Roche has increased median survival time for patients by an average of nearly sixteen months, according to health officials. The drug, known as Perjeta, was found to provide unprecedented success to fight the disease based on a recent clinical st...